Compare TELA & OPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TELA | OPTH |
|---|---|---|
| Founded | 2012 | 2020 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4M | 28.9M |
| IPO Year | 2019 | 2024 |
| Metric | TELA | OPTH |
|---|---|---|
| Price | $1.25 | $4.63 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $2.08 | N/A |
| AVG Volume (30 Days) | ★ 236.8K | 65.9K |
| Earning Date | 11-12-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $80,275,000.00 | N/A |
| Revenue This Year | N/A | $56.17 |
| Revenue Next Year | $9.24 | $82.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.84 | N/A |
| 52 Week Low | $0.50 | $4.00 |
| 52 Week High | $1.60 | $5.45 |
| Indicator | TELA | OPTH |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 47.10 |
| Support Level | $0.61 | $4.17 |
| Resistance Level | $1.22 | $5.15 |
| Average True Range (ATR) | 0.12 | 0.27 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 44.17 | 45.24 |
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.